New England Regional Minority Health Committee presents the 6th New England Regional Minority Health Conference
http://www.nermhc.com/
October 14, 15 & 16, 2009 Westin Hotel • Providence, RI
To assist academic institutions in meeting the current challenges noted above, in 1997 Harvard launched a new companion program, Leadership Development for Physicians in Academic Health Centers, to serve a wider array of physician leaders. This program has been developed for physicians (who are not chairs of clinical departments) who are interested in attending a rigorous leadership development and management education program.
The Program aims to bring together physicians who are in administrative positions in academic health centers, who are not chairs of clinical departments, and an interdisciplinary faculty for two weeks of intensive and systematic study of some of the critical leadership and management issues which face physicians in administrative positions and academic health centers.
Continuing Education Credit The Harvard School of Public Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The Harvard School of Public Health designates this educational activity for a maximum of 55 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
More information is available on the HSPH web site .
RC LIVE Lunches are open to all researchers at BWH and are connected to the RC e-mail series. Each month, come by and listen to the latest news from BWH research community leaders, ask your questions and stay for a free lunch.
Event Type: Seminar
Hosted by: Biomedical Research Institute (BRI)
This three-day course is designed to offer physicians and other clinicians the information and skills needed to provide high-quality, specialist-level palliative care to patients with life-threatening illnesses in a variety of practice settings. Through plenaries and workshops, participants will develop a toolbox of palliative care competencies and will learn from colleagues facing similar practice challenges.
The course will address the assessment and management of physical, psychological, social, spiritual, and existential sources of suffering experienced by patients and their families.
Sessions also focus on cultural issues, communication, prognostication, bereavement, management of various non-oncological conditions, the special needs of patients at various stages of the life cycle, and ethical, legal, and practical issues in the setting of advanced illness. Recent research in palliative care will also be included.
We invite all physicians and nurses working with patients and families near the end of life in any setting to attend
Course Objectives
This course is designed so that physicians and other clinicians will be able to:
1. Assess and manage the physical, psychological, social, and spiritual/existential distress of patients with life-limiting diseases, and their families.
2. Develop practical strategies for discussing patients’ fears, wishes, and goals for care near the end of life, for balancing hope and honesty in discussing treatment options, and for dealing with common ethical issues that arise in this setting..
3. Cultivate approaches to working with different diseases (e.g., cancer, heart failure, pulmonary disease, and dementia), challenging scenarios (e.g., withholding or withdrawing fluids and nutrition, addiction, palliative sedation), diverse settings (e.g., intensive care unit, long-term care).and special patient populations (e.g., pediatric, geriatric),
The 2009 Art & Science of Palliative Care Nursing courses focus on applying principles of palliative care nursing to the management of patients with chronic illnesses such as heart failure, ALS and renal disease. These courses are designed for nurses interested in palliative care.
In a continuing effort to “Go Green” we are offering an electronic version of the course syllabus which will be provided on the day of the course. A limited number of paper syllabi are available for pre-order purchase for an additional $8. If you wish to purchase a paper copy of the syllabus, please indicate this by checking off the appropriate box on the registration form and include the $8 amount in your total payment. Preorder paper versions of the syllabus will be given to you at the registration table on the day of the course.
Registration Forms:
Generalist Nursing Session July 21, 2009 - Course Full
Cancellation/Refund Policy: The cancellation fee is $50.00. If the participant must leave before the completion of the course, no refund will be made nor will education credits be provided.
Course Directors
Constance Dahlin, APRN, BC, PCM Advanced Practice Nurse, Palliative Care Service Massachusetts General Hospital Faculty, Harvard Medical School Center for Palliative Care
Maureen Lynch, MS, APRN, BC-PCM, AOCN Nurse Practitioner, Pain and Palliative Care Service Dana-Farber Cancer Institute Faculty, Harvard Medical School Center for Palliative Care
Honorary Lecturers 2009
Conor P. Delaney, MD, PhD University Hospitals, Case Medical Center Cleveland, Ohio
Torbjorn Holm, MD, PhD Karolinska Hospital Stockholm, Sweden
P. Terry Phang, MD University of British Columbia Vancouver, British Columbia
Registration is required, please refer to the homepage for a detailed itinerary.
Program Objectives
After attending the symposium, participants will be able to
Outline treatment strategies and multidisciplinary treatment planning for patients with cancer
Discuss targeted therapies and management of associated adverse events
Identify current standards of care for advanced colorectal cancer patients
Outline new treatment options for pancreatic cancer
Discuss new oncology agents and the evolving roles of chemotherapy and biologic agents
Discuss current topics relevant to cancer care and management
This symposium will provide participants with practical information to better care for patients with cancer.
Audience
The symposium is a forum for pharmacists, physicians, nurses, and other allied health professionals from all practice settings involved in the management of cancer patients.
Program Sessions
Learning Objectives Learning objectives are provided for each session. After attending each session, participants should be enabled to meet the stated objectives.
Attire for Symposium Please note that the attire for the symposium is business casual. Meeting room temperatures may vary and personal comfort ranges widely, so please bring a sweater or jacket to help assure your comfort.
Continuing Education
The Division of Pharmacy at The University of Texas M. D. Anderson Cancer Center is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The program has been approved for up to 15.50 contact hours (1.50 CEUs). Universal Program Number(s) for accredited sessions are noted. Continuing pharmacy education credit will be offered for all symposium educational sessions except the networking with colleagues and exhibit program sessions. To obtain a statement for continuing pharmaceutical education, the following requirements must be met:
• Submission of a completed certification of participation document
• Submission of a completed evaluation document
Statements of continuing pharmaceutical education credit will be mailed within 5 weeks following the symposium.
Symposium Coordinators
Sharon A. Bronson, MS, RPh – Co-chair Judy L. Chase, PharmD, FASHP – Program Mark A. Kramer, MS, RPh – Program Thomas L. Prudhomme, MBA, RPh – Exhibit Program Amy L. Perpich, PharmD – Exhibit Program Constance C. Tierney, CMP –CME/ Conference Management
Notes: Sep 29, 2009 - Oct 3, 2009 The Jackson Laboratory, Bar Harbor METhis is an intensive hands-on workshop designed to teach state-of-the-art methods used in the design and characterization of murine models for cancer research. This year’s focus will be colon cancer and neoplasia of the intestinal epithelium.Workshop Topics:
Tumor imaging in the laboratory mouse and rat Optical endoscopy Fluorescence MicroCT MicroPET UltrasoundSomatic genetics and epigenetics LOH assaysCellular assays Crypt isolation In situ hybridization Immunohistochemistry Assays for apoptosis in the intestine and its tumors Assays for signaling events The polarized epithelium
The transcriptome and proteome Array hybridization The proteome and it modification statesThis workshop can be used for continuing education units for AALAS recertification.
The Massachusetts Pain Initiative Fall 2009 General Meeting will be held on October 21, 2009
Time: Registration at 7:30 AM, meeting will run from 8:00 - 12:00 (includes council updates, presentation, and break-out council meetings)
Place: Publick House in Sturbridge, MA http://www.publickhouse.com/
Featured speaker: Jena Adams, MOLST Project Director, UMass Medical School Topic: Medical Orders for Life Sustaining Treatment (MOLST), a demonstration project currently underway
Cost is $20, includes continental breakfast and contact hours
If you have any questions please do not hesitate to contact us, and hope to see everyone at the Fall 2009 General Meeting.
info@masspaininitiative.org
CHAIRPERSONS: Carlos L. Arteaga, Vanderbilt-Ingram Cancer Center, Nashville, TN Lewis A. Chodosh, University of Pennsylvania, Philadelphia, PA Kornelia Polyak, Dana-Farber Cancer Institute, Boston, MA
Opening Keynote Address: Joan S. Brugge, Harvard Medical School, Boston, MA “Modeling breast cancer in cell culture”
Please use the link below to get more information and to register -
Offered by Dana-Farber/Brigham and Women's Cancer Center, Massachusetts General Hospital Cancer Center, and Harvard Medical School Department of Continuing Education, this course will provide an update on the advances in the treatment, management, and understanding of ovarian cancer. It is suitable for medical, surgical, and radiation oncologists; gynecologists; primary care physicians; nurse practitioners; and other interested clinicians.
Yen-Lin Evenly Chen, MD, Massachusetts General Hospital, Department of Radiation Oncology
Please remember that the lecture takes place in the Simches Conference Center 185 Cambridge Street, 3rd floor, Room 3110 from 9am-10am. This is a locked facility and requires a Partners or Harvard ID for entrance. Please contact me advance of the lecture if you need access.
VASCULAR BIOLOGY SEMINAR SERIES
October 1, 2009 4:30 PM
Speaker: EUGENE BRAUNWALD, MD
Distinguished Hersey Professor of Medicine, Harvard Medical School
Chairman, TIMI Study Group, Brigham and Women's Hospital
8th Annual RAMZI S. COTRAN Lecture
Title: “Emerging Insights into Antiplatelet Therapy”
Enders Auditorium
This Symposium offers a transformational look at where healthcare in this country is headed. It’s an ideas conference for healthcare and information technology, a gathering place where fresh thinking gets presented and tested. Over 1,000 healthcare professionals attended last year, and 2009 registrations are running way ahead of 2008’s. For a complete agenda, please visit the Center for Connected Health’s website.
http://www.connected-health.org/events/symposium-2009.aspx At Boston Park Plaza Hotel and Towers
If you are interested in attending, we have secured a discounted rate of $795. To obtain the Disparities Solutions Center discount rate of $795 for the entire two day event, register as "general public" at http://www.connected-health.org/ and type in "DSC " in the invitation code box. Then continue the registration process until finished.
Speakers Include: Nicholas Christakis, MD, PhD, MPH Professor of Medical Sociology, Harvard Medical School; TIME magazine's choice for its 2009 List of the World's 100 Most Influential People; and co-author with James Fowler, PhD, of 'Connected: The Surprising Power of Our Social Networks and How They Shape Our Lives', to be published in September 2009.
Peter Ubel, MD University of Michigan physician, Director of its Center for Behavioral and Decision Sciences in Medicine, and author of 'Free Market Madness: Why Economics is at Odds with Human Nature-and Why it Matters' (2009)
Stuart Altman, PhD Professor of National Health Policy, The Heller Graduate School for Social Policy and Management, Brandeis.
AWARE for All is an educational program that is free and open to the public for the purpose of providing education to help people make informed decisions about clinical research participation.
Highlights of the Day • Open to the public • Free gift if you bring a friend • Educational Workshops • Free Breakfast & Lunch • Free Health Screenings • Meet Local Area Doctors • Information and Exhibit Area • Learn what you need to know about clinical research,including questions to ask your doctor
Tufts Medical Center Atrium Lobby 800 Washington Street Boston, MA 02111
Beth Israel Deaconess Medical Center, Hematology/Oncology Grand Rounds
Speaker: Dr. Alan Venook, University of California, San Francisco
Presentation: "Hepatocellular Carcinoma: Progress at Last?"
4:00 - 5:00 p.m., Shapiro Cardiovascular Center, 3rd Floor Lounge
Brigham and Women’s Hospital, Boston
OMC Roundtable with Vivian Pinn, M.D.
Director, Office of Research on Women’s Health at the National Institutes of Health (NIH)
For registration please contact BWHOMC@partners.org
Sponsored by Brigham and Women’s Hospital Office for MulticulturalFacultyCareersCenter for Faculty Development and Diversity.
Speaker: Fernando S. Mendoza, M.D., M.P.H.
Professor and Chief, Division of General Pediatrics - Stanford School of Medicine
This lecture, in recognition of Latino Heritage Month, will address the health issues that afflict Latino children.
Co-sponsored by DCP/HMS; CHADD; HSPH Office for Diversity; MGH Multicultural Affairs Office; Children’s Hospital Boston Office of Faculty Development.
RSVP by Friday, October 9, 2009 Phone: 617-432-4698, Email: melissa_alexis@hms.harvard.edu
Please see the attached flyer for more details.
Harvard Catalyst Program for Faculty Development and Diversity Lecture
Speaker: Joel D. Oppenheim, Ph.D. - Senior Associate Dean for Biomedical Sciences, Director, the Sackler Institute for Graduate Biomedical Sciences - New York University School of Medicine
Co-sponsored by Harvard Catalyst PFDD; DCP/HMS.
This Program will provide participants with comprehensive and current information on career prospects and resources avaialble through federal agencies (AHRO, NIH, NSF). The goal is to guide attendees through the labyrinth of choices available to them and enable them to gain access to appropriate support and resources.
CME available
Preregistration is required and space is limited. Please contact Massachusetts Medical Society at 800-843-6356 for registration.
Co-sponsored by DCP/HMS; BSCP; CHADD; Harvard Catalyst PFDD; Massachusetts Medical Society
PRESENTERS: Francis D. Chesley, Jr., MD - Patricia A. Cole, PhD - Nancy L. Desmond, PhD - Frances E. Ferguson, MD, MPH - Joan Y. Reede, MD, MPH, MBA
Cost: $10
HSCI Seminar Series When: Tuesday, October 6, 2009 ~ 12:15-1:15 p.m. Where: MGH Main Campus, Simches Research Building, Auditorium 3.110, 185 Cambridge St., Boston, MA Guest speaker: Frank C. Marini, III, PhD University of Texas / MD Anderson Cancer Center Faculty host: Jeff Karp, PhD (BWH) Pizza and beverages will be served.
For 2009-2010, the HSCI Seminar Series is exclusively sponsored by Stemgent.
The LAM Treatment Alliance is pleased to announce the kick-off of our 2009-2010 LAM/TSC Seminar Series. Mehmet Toner, PhD, and Sunitha Nagrath, PhD, will make a presentation focused on breakthrough microchip technology to help detect and capture circulating tumor cells and work-in-progress focused on optimizing that technology for use in patients with LAM (lymphangioleiomyomatosis). Join us in person or remotely via webcast. Presentation will be followed by discussion, a light dinner and informal networking. CME credit available. RSVPs requested.
Brain micro-metastases:Models and immune therapies
Lois Lampson, Ph.D.
Associate Professor of Neurosurgery
Brigham and Women's Hospital/ Harvard Medical School
Friday, October 16, 2009
10:30 - 11:30 am
Pathology Conference Room
Brigham and Women's Hospital
Amory 3
Please join us for the Ruth C. Brufsky Memorial Lecture in Medical Ethics "Consequences of Unprofessional Behavior in Trainees" Maxine Papadakis, MD Clinical Professor of Medicine Associate Dean for Student Affairs University of California San Francisco Monday, October 19th 12 noon - 1:00pm Smith Family Room, Dana 1620 Dana-Farber Cancer Institute Lunch will be served at 11:45; Rounds will begin at noon Risk Management CME credits will be provided Contact:Steven Joffe, MD, MPH
"Functionalizing the Cancer Genome"
Lynda Chin, MD
Dana-Farber Cancer Institute
with Discussant
Elizabeth (Lisa) Henke, MD
Brigham and Women's Hospital
Join us in person or remotely via live webcast on
Thursday, Oct. 22, 2009, from 5 to 7 pm EDT.
Presentation will be followed by discussion, a light dinner and informal networking.
This and all upcoming sessions will be streamed live on the Internet with password protection. To participate remotely, please email ltaadmin@lamtreatmentalliance.ord to request the password. Requests must be submitted no later than 11 am EDT on Thursday, Oct. 22.
SPEAKERS: Lynda Chin, MD is Associate Professor of Dermatology at Harvard Medical School and Associate Professor of Oncology at Dana-Farber Cancer Institute, where she conducts research in the areas of Genetics and Biology of Tumor Genesis, Progression, and Maintenance. Dr. Chin received her MD in 1993 and postgraduate training in dermatology from the Albert Einstein College of Medicine. During her research fellowship, Dr. Chin contributed to an understanding of the interactions among members of the myc superfamily and to the discovery of the Sin3-HDAC corepressor complex. Since joining DFCI in 1998, her laboratory has focused on the identification and molecular characterization of known and novel genes involved in melanoma and glioma genesis and progression..
LOCATION: New Research Building (NRB), Harvard Medical School, 77 Avenue Louis Pasteur, Room 350, Boston
PARKING: Free parking in the lot below the NRB has been graciously donated by the Department of Genetics, Harvard Medical School. Please request parking by 10 am EDT on Oct. 22. Please RSVP for the meeting as well as parking by emailing ltaadmin@lamtreatmentalliance.org
Thank you for your interest and participation. We appreciate your help in circulating this announcement to relevant researchers, labs and clinicians. We look forward to seeing you or hearing from you via chat online on Oct. 22!
PAST MEETINGS: To access information or videos related to past meetings, visit http://lamtreatmentalliance.org/past_seminars1.html
UPCOMING MEETINGS:
Nov. 12, 2009: LAM/TSC Post-Doctoral/Graduate Student International Poster Session Competition - in-person and virtual submissions!
We cordially invite you to this presentation in our DF/HCC Pipelines in Oncology Series.
October 15, 2009: Merrimack Pharmaceuticals
Presentation at 7:30 AM at MGH, Simches 3130 followed by 1:1 meetings in LRH 2 Conference Room
Presenters from Merrimack will be:
Ulrik Nielsen, PhD, Chief Scientific Officer
Clet Niyikiza, PhD Senior Vice President, Development
and Victor Moyo, MD, Medical Director
2nd Presentation at Noon at DFCI (Mayer 660) followed by 1:1 meetings in Dana 1608
Presentation will focus on: MM-121, an ErbB3 antagonist, and MM-111, a bispecific antibody targeting ErbB2/3. The company will be discussing how these two programs were discovered and developed and our thoughts on how they will be applied clinically.
October 15, 2009: Merrimack Pharmaceuticals
Presenters from Merrimack will be:
Ulrik Nielsen, PhD, Chief Scientific Officer
Clet Niyikiza, PhD Senior Vice President, Development
and Victor Moyo, MD, Medical Director
Presentation at Noon at DFCI (Mayer 660) followed by 1:1 meetings in Dana 1608
Presentation will focus on: MM-121, an ErbB3 antagonist, and MM-111, a bispecific antibody targeting ErbB2/3. The company will be discussing how these two programs were discovered and developed and our thoughts on how they will be applied clinically.
Offered by Dana-Farber/Brigham and Women's Cancer Center, Massachusetts General Hospital Cancer Center, Beth Israel Deaconess Medical Center, and Harvard Medical School Department of Continuing Education.
Attendees will learn about standard treatment for melanoma, novel therapies being explored, and how surgery can be used to manage the disease. The role that genetics plays in the disease will also be discussed.
As many of you might know, there are many compelling reasons to explore building a culturally competent organization - the primary goal being to provide the highest quality of care to all patients. However, the regulatory landscape is also changing and whether an organization is ready or not - they will need to be responsible for providing cultural competency training for all their healthcare staff.
Dr. Green will review the draft standards recently published by the Joint Commission, as well as additional regulations requiring healthcare organizations to provide cultural competency training for accreditation. He will also review training solutions that hospitals and health plans have implemented around the country.
To register for the webinar on Thursday, October 15, 2009 at 3:00 PM EST, please click here .
To register for the webinar on Monday, October 26, 2009, at 12:00 PM EST, please click here .
The webinar is approximately 40 minutes in length and will be followed by a live question and answer session with Dr. Alex Green.
About Alexander Green, MD, MPH Dr. Alex Green is Associate Director at the Disparities Solutions Center at Massachusetts General Hospital and Assistant Professor and Chair of the Cross-Cultural Care Committee at Harvard Medical School. He has authored articles on topics including cross-cultural education, culturally competent health care systems, and language barriers and interpreters, and has presented his work widely.
About Manhattan Cross Cultural Group Manhattan Cross Cultural Group is a training and research organization committed to improving health care to diverse patient populations and eliminating health disparities. MCCG was founded by Drs. Joseph Betancourt, Alexander Green and Emilio Carrillo - three practicing physicians and thought-leaders in the field of cross-cultural health care. Collectively, they have worked with top governmental agencies, leading hospitals, foundations, and managed care organizations to further the goal of achieving high quality care for all patients. They have published several important articles including one that summarizes their approach to cross-cultural health care in the Annals of Internal Medicine and is the basis for the Quality Interactions program. (Cross-Cultural Primary Care: A Patient-Based Approach.Ann Intern Med. 1999;130:829-834)
October 22, 2009: Giovanni Parmigiani
Modeling Risk in Families with Cancer
Abstract: Identifying individuals at high risk of cancer because of inherited genetic susceptibility is complex and increasingly important. Probabilistic prediction algorithms that exploit domain knowledge of Mendelian inheritance and other biological characteristics of susceptibility genes successfully contribute to improved cancer screening, prevention, and genetic testing, and to the design and analysis of cancer studies. I will first briefly present the principles behind three Mendelian models: BRCAPRO for the BRCA genes, MMRpro for HNPCC, and PancPRO for pancreatic cancer, focusing on recent progress including incorporation on molecular markers. I will then discuss issues in validation studies of risk models in high risk family studies, and present some of the challenging that remain to be addressed.
Light refreshments will be available.
Applying Nanoscale Technologies in Biomedical Research: A Workshop
Synergy Series of the Harvard Catalyst Research Navigators
When: Wednesday, October 14, 2009 ~ 4:30-6:00 p.m.
Where: Harvard Medical School, Countway Library, 10 Shattuck Street, Boston, MA
The Harvard Catalyst Research Navigators and the Center for Nanoscale Systems (CNS) at the Harvard University Faculty of Arts and Sciences cordially invite biomedical researchers interested in nanoscale technologies to a workshop on October 14, 2009. This session will feature an overview of CNS resources, as well as speakers from the Harvard community who will illustrate and discuss applications of those resources in biomedical research. The goal is to bring together a diverse group of investigators to explore how nanotechnology might be brought to bear on biomedical questions.
Refreshments will be provided, and there will be ample time for networking.
CNS is an important resource for biomedical research across Harvard University and its affiliated academic health care centers. It operates and maintains large, centralized scientific facilities in research areas related to electron microscopy, nanofabrication, and materials synthesis. In all of these areas, CNS strives to create a community of scientists that are interacting and collectively doing some of the most innovative research at the nanoscale. In the 10 years since its inception, CNS has been involved in more than 100 projects from Harvard Medical School and its affiliates.
Attendance at this event is limited to 40 individuals, and registration is required; attendees should RSVP by October 7. Please send your name, contact information, home department and institution, and a brief description of your research interests to Amy Webber , or by calling 617-432-7810.
The Harvard Catalyst Research Navigators are committed to providing opportunities for collaboration by organizing scientists and clinicians around research resources, areas of investigation, and disease topics. This event is part of the Synergy Series, a series of seminars and workshops designed to increase connectivity in the Harvard Catalyst community.
Stem Cells: Niche, Competition and Aging
HSCI Seminar Series
When: Tuesday, October 20, 2009 ~ 12:15-1:15 p.m.
Where: MGH Main Campus, Simches Research Building, Auditorium 3.110, 185 Cambridge St., Boston, MA
Guest speaker: Ting Xie, PhD Stowers Medical Institute
Faculty host: Zhong Wang, PhD (MGH)
Pizza and beverages will be served.
For 2009-2010, the HSCI Seminar Series is exclusively sponsored by Stemgent
"IL-6/JAK/Stat3 Signaling and Tumorgenesis" Dana-Farber Cancer Institute Seminars in Oncology
When: Tuesday, October 20, 2009 ~ 4:00-5:00p.m.
Description: Jacqueline F. Bromberg, MD, PhD Associate Professor of Medicine Memorial Sloan-Kettering Cancer Center, NY, NY
Host: David Frank, MD, PhD (617-632-4750)
Friday, October 30, 2009
10:30 am - 11:30 am
Pathology Conference Room
Brigham and Women's Hospital
Amory 3
CONFERENCE TITLE: Convexity and Falx Meningiomas
Peter Black, M.D., Ph.D.
Franc D. Ingraham Professor of Neurosurgery
Harvard Medical School
Founding Chair, Department of Neurosurgery
Brigham and Women’s Hospital
Neurosurgeon-in-Chief, Emeritus
Children’s Hospital
Dana-Farber/Harvard Cancer Center
A Comprehensive Cancer Center
Designated by the National Cancer Institute
principles of palliative care nursing to the management of patients with chronic illnesses such as heart failure, ALS and renal disease. These courses are designed for nurses interested in palliative care. 